(Q50425077)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

Anti-metastatic immunotherapy based on mucosal administration of flagellin and immunomodulatory P10 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Niels Camara

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json

Luis Carlos de Souza Ferreira

16 February 2020

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Filipe M de Melo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Catarina J M Braga

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Felipe V Pereira

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Juliana T Maricato

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Clarice S T Origassa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Mariana F Souza

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Amanda C Melo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Priscila Silva

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Samanta L Tomaz

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Karina P Gimenes

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Jorge A B Scutti

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Maria A Juliano

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Luiz R Travassos

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Elaine G Rodrigues

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

16 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json

Immunology & Cell Biology

16 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

86-98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json

Systematic review of medical treatment in melanoma: current status and future prospects.

16 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Combination of targeted therapy and immunotherapy in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

The three Es of cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Natural innate and adaptive immunity to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Does the immune system see tumors as foreign or self?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Endogenous accumulation of IFN-gamma in IFN-gamma-R(-/-) mice increases resistance to B16F10-Nex2 murine melanoma: a model for direct IFN-gamma anti-tumor cytotoxicity in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Gene expression changes and signaling events associated with the direct antimelanoma effect of IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Mouse tumor vasculature expresses NKG2D ligands and can be targeted by chimeric NKG2D-modified T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Transforming growth factor-beta regulation of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-γ-dependent response against B16F10-Nex2 melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Multiple roles for CD4+ T cells in anti-tumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Augmented induction of CD8+ cytotoxic T-cell response and antitumour resistance by T helper type 1-inducing peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

The role of adjuvants in therapeutic protection against paracoccidioidomycosis after immunization with the P10 peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Paracoccidioidomycosis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Additive effect of P10 immunization and chemotherapy in anergic mice challenged intratracheally with virulent yeasts of Paracoccidioides brasiliensis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

T-cell recognition of Paracoccidioides brasiliensis gp43-derived peptides in patients with paracoccidioidomycosis and healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Paracoccidioides brasiliensis vaccine formulations based on the gp43-derived P10 sequence and the Salmonella enterica FliC flagellin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Flagellin as an adjuvant: cellular mechanisms and potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Mucosal administration of flagellin induces innate immunity in the mouse lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimurium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Simultaneous targeting of toll- and nod-like receptors induces effective tumor-specific immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Distribution of primed T cells and antigen-loaded antigen presenting cells following intranasal immunization in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Tumour-associated macrophages and melanoma tumourigenesis: integrating the complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Formation and structure of a NAIP5-NLRC4 inflammasome induced by direct interactions with conserved N- and C-terminal regions of flagellin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

A TLR5 agonist inhibits acute renal ischemic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

TLR agonists: our best frenemy in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Antitumor activity of the TLR-5 ligand flagellin in mouse models of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

The inflammasome NLRs in immunity, inflammation, and associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

CD4+ TH1 cells generated by Ii-PADRE DNA at prime phase are important to induce effectors and memory CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Strong humoral response elicited by a DNA vaccine targeting gastrin-releasing peptide with optimized adjuvants inhibits murine prostate carcinoma growth in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Immunization with Th-CTL Fusion Peptide and Cytosine-Phosphate-Guanine DNA in Transgenic HLA-A2 Mice Induces Recognition of HIV-Infected T Cells and Clears Vaccinia Virus Challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Linear PADRE T helper epitope and carbohydrate B cell epitope conjugates induce specific high titer IgG antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Essentials of Th17 cell commitment and plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Soluble flagellin, FliC, induces an Ag-specific Th2 response, yet promotes T-bet-regulated Th1 clearance of Salmonella typhimurium infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Transcriptional reprogramming of mature CD4⁺ helper T cells generates distinct MHC class II-restricted cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Enhancement of tumor-reactive cytotoxic CD4+ T cell responses after ipilimumab treatment in four advanced melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Analyzing real-time PCR data by the comparative C(T) method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunity

21 January 2018

1 reference

12 December 2020

Dual character of Toll-like receptor signaling: pro-tumorigenic effects and anti-tumor functions

1 reference

12 December 2020

The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection

1 reference

12 December 2020

1 reference

12 December 2020

Mapping of the T-cell epitope in the major 43-kilodalton glycoprotein of Paracoccidioides brasiliensis which induces a Th-1 response protective against fungal infection in BALB/c mice

1 reference

12 December 2020

Removal of endotoxin from protein solutions by phase separation using Triton X-114

1 reference

12 December 2020

Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells

1 reference

12 December 2020

Biological behavior of malignant melanoma cells correlated to their survival in vivo

1 reference

12 December 2020

Altered inflammatory responses in TLR5-deficient mice infected with Legionella pneumophila

1 reference

12 December 2020

In silico prediction of peptides binding to multiple HLA-DR molecules accurately identifies immunodominant epitopes from gp43 of Paracoccidioides brasiliensis frequently recognized in primary peripheral blood mononuclear cell responses from sensitiz

1 reference

12 December 2020

Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.

1 reference

12 December 2020

Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.74

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/ICB.2014.74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25223833%20AND%20SRC:MED&resulttype=core&format=json